• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM TOTAL HCG (THCG) ASSAY; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM TOTAL HCG (THCG) ASSAY; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/28/2023
Event Type  malfunction  
Manufacturer Narrative
The customer reports observation of a discordant elevated total hcg (thcg) result for a patient sample on atellica im 1600 analyzer.The initial result was reported to the physician(s), who questioned the result.The sample was repeated on the same atellica im analyzer and two other atellica im analyzers and lower results were obtained.Calibration and quality controls (qc) were within the expected ranges for thcg.The interpretation of results section of the atellica im total hcg (thcg) instructions for use (ifu) states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens healthcare diagnostics is investigating.
 
Event Description
The customer reports observation of a discordant elevated total hcg (thcg) result for a patient sample on atellica im 1600 analyzer.The initial result was reported to the physician(s), who questioned the result.The sample was repeated on the same atellica im analyzer and two other atellica im analyzers and lower results were obtained.There are no known reports of patient intervention or adverse health consequences due to the discordant, total hcg (thcg) result.
 
Manufacturer Narrative
Initial mdr 1219913-2023-00300 was filed on 23-nov-2023.Section d8: was this device serviced by a third party? updated to no.Additional information - (b)(6) 2023: sid# (b)(6) discordant result on (b)(6) on (b)(6) 2023 16:52:14 gmt: 29.4 miu/ml repeat on the same system on (b)(6) 2023: <2.0 miu/ml review of reagent trace files: there is no evidence of a hardware issue that is impacting delivery of thcg reagents.Review of sample trace files: there is no evidence of a hardware issue that is impacting delivery of 25ul of sample.
 
Manufacturer Narrative
Initial mdr 1219913-2023-00300 was filed on 23-nov-2023 and the mdr 1219913-2023-00300 supplemental report 1 was filed on 21-dec-2023.Additional information - 21-dec-2023: the customer reported a falsely elevated discordant patient result on the atellica im total hcg (thcg) assay.On 28-oct-2023, the sample initially resulted in 29.4 miu/ml.The sample was repeated on the same analyzer the following day with a result of <2.0 miu/ml.The sample was also repeated on two other atellica im analyzers with results of <2 miu/ml.The lower repeat results were considered correct.The thcg calibration and quality control (qc) results were within expected ranges on the day of this event.Siemens reviewed the sample and reagent trace files for sid # (b)(6).There was no evidence of a hardware issue that impacted the delivery of thcg lite and solid phase reagents.A review of the sample trace file showed no evidence of a hardware issue that impacted the delivery of 25ul of sample.Based on available information, the cause of the discordant result is consistent with a sample integrity issue.The problem was isolated to just one sample, and the instrument is operational.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM TOTAL HCG (THCG) ASSAY
Type of Device
SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict ave
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney st.
east walpole, MA 02032
7818564812
MDR Report Key18197953
MDR Text Key328891184
Report Number1219913-2023-00300
Device Sequence Number1
Product Code DHA
UDI-Device Identifier00630414600024
UDI-Public00630414600024
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K192790
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 01/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/23/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/14/2024
Device Model NumberN/A
Device Catalogue Number10995689
Device Lot Number350
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/14/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age41 YR
Patient SexFemale
-
-